Parisi Ortensia Ilaria, Scrivano Luca, Amone Fabio, Malivindi Rocco, Ruffo Mariarosa, Vattimo Anna Francesca, Pezzi Vincenzo, Puoci Francesco
Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, 87036 Rende (CS), Italy.
Macrofarm s.r.l., c/o Department of Pharmacy, Health and Nutrition Sciences, University of Calabria, 87036 Rende (CS), Italy.
J Funct Biomater. 2018 Jul 12;9(3):44. doi: 10.3390/jfb9030044.
Hair loss represents a condition that adversely affects the social life of patients. The most common cause is androgenetic alopecia (AGA), which is a genetically determined progressive hair-loss condition involving 5α-reductase. In this study, a novel anti-baldness agent based on Interconnected PolymerS TeChnology (IPSTiC), which is an effective strategy for the delivery of bioactive molecules, was developed. This product (IPSTiC patch hair) is based on a polymeric blend consisting of high molecular weight hyaluronic acid and soybean proteins and is able to improve efficacy and stability of bioactive ingredients such as leaf extract, leaf extract, and fruit extract. The efficacy of the developed anti-baldness agent was investigated by performing several tests including NO radical and 5α-reductase inhibition assays, stability studies under different conditions, and in vitro diffusion studies using Franz cells. The biocompatibility of IPSTiC patch hair was also evaluated by in vitro analysis of the pro-sensitising potential and EPISKIN model. The obtained results confirmed both the efficacy and safety of IPSTiC patch hair supporting the potential use of this product in the topical treatment of AGA.
脱发是一种对患者社交生活产生不利影响的病症。最常见的原因是雄激素性脱发(AGA),这是一种由基因决定的、涉及5α-还原酶的进行性脱发病症。在本研究中,基于互联聚合物技术(IPSTiC)开发了一种新型抗脱发剂,这是一种递送生物活性分子的有效策略。该产品(IPSTiC贴片式头发)基于由高分子量透明质酸和大豆蛋白组成的聚合物共混物,能够提高叶提取物、叶提取物和果实提取物等生物活性成分的功效和稳定性。通过进行包括NO自由基和5α-还原酶抑制试验、不同条件下的稳定性研究以及使用Franz扩散池的体外扩散研究等多项测试,对所开发的抗脱发剂的功效进行了研究。还通过对致敏潜力和EPISKIN模型的体外分析评估了IPSTiC贴片式头发的生物相容性。所得结果证实了IPSTiC贴片式头发的功效和安全性,支持该产品在AGA局部治疗中的潜在应用。